Real-time market data and insights.
| Date | Insider | Shares | Price |
|---|---|---|---|
| 2025-09-03 | Seehra Jasbir | +90,500 | $0 |
| 2025-09-03 | Seehra Jasbir | +90,500 | $0 |
| 2025-06-04 | Farzan Nima | +5,250 | $0 |
| 2025-06-04 | Seth Alpna | +5,250 | $0 |
| 2025-06-04 | Knowles Julius | +5,250 | $0 |
| 2025-06-04 | Kariv Tomer | +5,250 | $0 |
| 2025-06-04 | GORDON CARL L | +5,250 | $0 |
| 2025-06-04 | GRAY MARY ANN | +5,250 | $0 |
| 2025-06-04 | Nussbaum Ran | +5,250 | $0 |
| 2025-06-04 | BIENAIME JEAN JACQUES | +5,250 | $0 |
| 2025-06-04 | GRAY MARY ANN | +5,250 | $0 |
| 2025-06-04 | Nussbaum Ran | +5,250 | $0 |
| 2025-06-04 | Farzan Nima | +5,250 | $0 |
| 2025-06-04 | Kariv Tomer | +5,250 | $0 |
| 2025-06-04 | Knowles Julius | +5,250 | $0 |
| 2025-06-04 | GORDON CARL L | +5,250 | $0 |
| 2025-06-04 | Seth Alpna | +5,250 | $0 |
| 2025-06-04 | BIENAIME JEAN JACQUES | +5,250 | $0 |
| Date | Insider | Shares | Price |
|---|---|---|---|
| 2026-02-19 | Seehra Jasbir | -7,015 | $16.170000076293945 |
| 2026-02-18 | Lerner Lorena Raquel | -3,873 | $16.350000381469727 |
| 2026-02-18 | Regnante Keith | -4,739 | $16.350000381469727 |
| 2026-02-18 | Cho Esther | -4,745 | $16.350000381469727 |
| 2025-11-21 | OrbiMed Genesis GP LLC | -140,057 | $17.75 |
| 2025-11-21 | OrbiMed Genesis GP LLC | -140,057 | $17.75 |
| 2025-11-21 | OrbiMed Capital GP VII LLC | -74,465 | $17.75 |
| 2025-11-21 | GORDON CARL L | -140,057 | $17.75 |
| 2025-11-21 | OrbiMed Capital GP VII LLC | -140,057 | $17.75 |
| 2025-11-21 | Knowles Julius | -191,527 | $17.75 |
| 2025-11-21 | OrbiMed Genesis GP LLC | -74,465 | $17.75 |
| 2025-11-21 | GORDON CARL L | -74,465 | $17.75 |
| 2025-11-21 | OrbiMed Genesis GP LLC | -140,057 | $17.75 |
| 2025-11-21 | ORBIMED ADVISORS LLC | -140,057 | $17.75 |
| 2025-11-21 | OrbiMed Capital GP VII LLC | -74,465 | $17.75 |
| 2025-11-21 | OrbiMed Capital GP VII LLC | -140,057 | $17.75 |
| 2025-11-21 | OrbiMed Capital GP VII LLC | -74,465 | $17.75 |
| 2025-11-21 | OrbiMed Capital GP VII LLC | -140,057 | $17.75 |
| 2025-11-21 | ORBIMED ADVISORS LLC | -74,465 | $17.75 |
| 2025-11-21 | OrbiMed Genesis GP LLC | -74,465 | $17.75 |
| 2025-11-21 | GORDON CARL L | -140,057 | $17.75 |
| 2025-11-21 | OrbiMed Genesis GP LLC | -140,057 | $17.75 |
| 2025-11-21 | OrbiMed Capital GP VII LLC | -140,057 | $17.75 |
| 2025-11-21 | ORBIMED ADVISORS LLC | -140,057 | $17.75 |
| 2025-11-21 | Knowles Julius | -130,494 | $17.75 |
| 2025-11-21 | Knowles Julius | -130,494 | $17.75 |
| 2025-11-21 | OrbiMed Genesis GP LLC | -74,465 | $17.75 |
| 2025-11-21 | GORDON CARL L | -140,057 | $17.75 |
| 2025-11-21 | ORBIMED ADVISORS LLC | -140,057 | $17.75 |
| 2025-11-21 | OrbiMed Genesis GP LLC | -140,057 | $17.75 |
| 2025-11-21 | Knowles Julius | -130,494 | $17.75 |
| 2025-11-21 | ORBIMED ADVISORS LLC | -74,465 | $17.75 |
| 2025-11-21 | OrbiMed Genesis GP LLC | -74,465 | $17.75 |
| 2025-11-21 | OrbiMed Capital GP VII LLC | -74,465 | $17.75 |
| 2025-11-21 | ORBIMED ADVISORS LLC | -140,057 | $17.75 |
| 2025-11-21 | OrbiMed Genesis GP LLC | -74,465 | $17.75 |
| 2025-11-21 | Knowles Julius | -191,527 | $17.75 |
| 2025-11-21 | GORDON CARL L | -74,465 | $17.75 |
| 2025-11-21 | Knowles Julius | -191,527 | $17.75 |
| 2025-11-21 | ORBIMED ADVISORS LLC | -74,465 | $17.75 |
| 2025-11-21 | GORDON CARL L | -74,465 | $17.75 |
| 2025-11-21 | ORBIMED ADVISORS LLC | -74,465 | $17.75 |
| 2025-10-15 | Nussbaum Ran | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (China) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage GP Ltd. | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Capital Management GP, LLC | -743,358 | $17.75 |
| 2025-10-15 | Pontifax Late Stage GP Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Kariv Tomer | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage GP Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Israel) IV, L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage Fund L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Management 4 G.P. (2015) Ltd. | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Capital Management GP, LLC | -743,358 | $17.75 |
| 2025-10-15 | Pontifax (China) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Cayman) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Partners, LP | -743,358 | $17.75 |
| 2025-10-15 | Pontifax Late Stage GP Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Israel) IV, L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Israel) IV, L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (China) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Cayman) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage Fund L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Cayman) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Cayman) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Kariv Tomer | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Cayman) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Partners, LP | -743,358 | $17.75 |
| 2025-10-15 | Pontifax Late Stage Fund L.P. | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Capital Management GP, LLC | -743,358 | $17.75 |
| 2025-10-15 | Pontifax Late Stage Fund L.P. | -155,262 | $17.75 |
| 2025-10-15 | Kariv Tomer | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Capital Management, LLC | -743,358 | $17.75 |
| 2025-10-15 | Pontifax Late Stage GP Ltd. | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Capital Management, LLC | -743,358 | $17.75 |
| 2025-10-15 | Nussbaum Ran | -155,262 | $17.75 |
| 2025-10-15 | Schneeberger Daniel | -743,358 | $17.75 |
| 2025-10-15 | Pontifax (Cayman) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Management 4 G.P. (2015) Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Kariv Tomer | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (China) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage GP Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Nussbaum Ran | -155,262 | $17.75 |
| 2025-10-15 | Nussbaum Ran | -2,284,612 | $17.75 |
| 2025-10-15 | Schneeberger Daniel | -4,391,237 | $17.75 |
| 2025-10-15 | ADAR1 Partners, LP | -743,358 | $17.75 |
| 2025-10-15 | Pontifax (Israel) IV, L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage Fund L.P. | -155,262 | $17.75 |
| 2025-10-15 | Nussbaum Ran | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Management 4 G.P. (2015) Ltd. | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Capital Management, LLC | -743,358 | $17.75 |
| 2025-10-15 | Pontifax Late Stage Fund L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Management 4 G.P. (2015) Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Management 4 G.P. (2015) Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (China) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Israel) IV, L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Management 4 G.P. (2015) Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Management 4 G.P. (2015) Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage Fund L.P. | -155,262 | $17.75 |
| 2025-10-15 | Kariv Tomer | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Israel) IV, L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Cayman) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage GP Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Kariv Tomer | -155,262 | $17.75 |
| 2025-10-15 | Schneeberger Daniel | -743,358 | $17.75 |
| 2025-10-15 | Pontifax (China) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Kariv Tomer | -155,262 | $17.75 |
| 2025-10-15 | Nussbaum Ran | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage Fund L.P. | -155,262 | $17.75 |
| 2025-10-15 | Kariv Tomer | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Management 4 G.P. (2015) Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Management 4 G.P. (2015) Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage GP Ltd. | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Capital Management GP, LLC | -743,358 | $17.75 |
| 2025-10-15 | Nussbaum Ran | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (China) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Nussbaum Ran | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Capital Management, LLC | -743,358 | $17.75 |
| 2025-10-15 | Schneeberger Daniel | -743,358 | $17.75 |
| 2025-10-15 | ADAR1 Partners, LP | -743,358 | $17.75 |
| 2025-10-15 | Pontifax (China) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Cayman) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Israel) IV, L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage GP Ltd. | -155,262 | $17.75 |
| 2025-10-15 | Nussbaum Ran | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Israel) IV, L.P. | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Capital Management GP, LLC | -743,358 | $17.75 |
| 2025-10-15 | ADAR1 Capital Management, LLC | -743,358 | $17.75 |
| 2025-10-15 | Nussbaum Ran | -155,262 | $17.75 |
| 2025-10-15 | Pontifax Late Stage Fund L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (Israel) IV, L.P. | -155,262 | $17.75 |
| 2025-10-15 | Pontifax (China) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Schneeberger Daniel | -743,358 | $17.75 |
| 2025-10-15 | Schneeberger Daniel | -743,358 | $17.75 |
| 2025-10-15 | Pontifax (Cayman) IV L.P. | -155,262 | $17.75 |
| 2025-10-15 | Kariv Tomer | -155,262 | $17.75 |
| 2025-10-15 | ADAR1 Partners, LP | -743,358 | $17.75 |
Macro correlation analysis loading...